Skip to content

A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy

A Phase II Multi Centre Study to Assess the Safety and Performance of Two Prototype One Piece Pouches in Subjects With an Ileostomy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01782196
Acronym
U366
Enrollment
13
Registered
2013-02-01
Start date
2012-10-31
Completion date
2013-03-31
Last updated
2013-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy

Brief summary

Certain research and innovation projects require an assessment of the adhesive properties of adhesives, which cannot be established from in-vitro testing. The most valuable data for assessments of this type comes from adhesion and wear time studies involving application to living human skin on volunteers. The purpose of the study is to assess the safety and performance of an enhanced one piece drainable pouch with a mouldable skin barrier wafer in a group of subjects with an ileostomy.

Interventions

DEVICEEnhanced one piece drainable pouch with Type A mouldable adhesive
DEVICEEnhanced one piece drainable pouch with Type B mouldable adhesive

Sponsors

ConvaTec Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects who provide written informed consent. * Subjects who have an ileostomy and be over 18 years of age. * Subjects who are currently using a one piece drainable pouch. * Subjects who have unbroken peri-stomal skin (healthy normal skin defined as normal unbroken skin with certain variations normal for this subject to L1 on the SACs Instrument Scale). * Subjects with a stoma considered 'normal' in appearance in accordance with the stoma, colour, moisture and structure rating scales. * Subjects who are willing to attend clinic for a maximum of 5 separate occasions for scheduled visits. * Subjects who are willing to discontinue the use of pastes, adhesive strips and rings/seals used to seal the area between the skin barrier wafer and stoma during the use of the study device. * Subjects who other than their ileostomy considered to have a healthy/stable health status. * Subjects who have good manual dexterity and be able to take care of their stoma independently, or have a consistent care provider. * Subjects who are willing and able to complete a diary card for the duration of the study.

Exclusion criteria

* Subjects with a history of sensitivity to any one of the ostomy products or the components being studied. * Subjects with stoma duration of less than 3 months. * Subjects who currently use a belt with their usual appliance. * Subjects who have been entered into the study before, or who have previously taken part in a study in the last month. * Subjects who require convexity or other skin fillers (pastes, rings, seals) to even undulations of the skin. * Subjects undergoing chemotherapy or radiotherapy. * Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study.

Design outcomes

Primary

MeasureTime frameDescription
Safety - evaluated by the nature and frequency of adverse events including stomal and peristomal skin condition and lesions59 daysThe primary objective of this study is to evaluate the safety of the enhanced one piece drainable pouch with a mouldable skin barrier wafer and two alternate adhesives in subjects with an ileostomy.

Secondary

MeasureTime frameDescription
Performance59 daysPerformance will be evaluated by comparing the following categories to the subject's usual pouching system Wear time Adhesion Ease of Use Mouldability Comfort and flexibility Security Skin protection Wafer seal integrity Undermining Filter performance Accessory usage At the end of the study a comparative assessment of the subject's usual pouching system and the study pouch will be made.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026